{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:52:55Z","timestamp":1770972775723,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1245\/s10434-025-17330-9","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:14:04Z","timestamp":1745579644000},"page":"5300-5305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy"],"prefix":"10.1245","volume":"32","author":[{"given":"Michelle M.","family":"Dugan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate E.","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle K.","family":"DePalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Elleson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Mullinax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amod A.","family":"Sarnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon K.","family":"Sondak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-4468","authenticated-orcid":false,"given":"Jonathan S.","family":"Zager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"17330_CR1","unstructured":"NCCN. National comprehensive cancer network (nccn) clinical practice guidelines in (nccn guidelines\u00ae), melanoma: Cutaneous. Nccn; 2024. Accessed December 16, 2024."},{"issue":"6","key":"17330_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-022-01851-x","volume":"28","author":"ILM Reijers","year":"2022","unstructured":"Reijers ILM, Menzies AM, van Akkooi ACJ, et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the Prado trial. Nat Med. 2022;28(6):1178\u201388. https:\/\/doi.org\/10.1038\/s41591-022-01851-x.","journal-title":"Nat Med."},{"issue":"5","key":"17330_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/bjs.11168","volume":"106","author":"B Schermers","year":"2019","unstructured":"Schermers B, Franke V, Rozeman EA, et al. Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage iii melanoma. Br J Surg. 2019;106(5):519\u201322. https:\/\/doi.org\/10.1002\/bjs.11168.","journal-title":"Br J Surg."},{"issue":"10","key":"17330_CR4","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1245\/s10434-009-0602-6","volume":"16","author":"M de Vries","year":"2009","unstructured":"de Vries M, Hoekstra HJ, Hoekstra-Weebers JE. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16(10):2840\u20137. https:\/\/doi.org\/10.1245\/s10434-009-0602-6.","journal-title":"Ann Surg Oncol."},{"key":"17330_CR5","doi-asserted-by":"publisher","first-page":"107327482412379","DOI":"10.1177\/10732748241237907","volume":"31","author":"KE Beekman","year":"2024","unstructured":"Beekman KE, DePalo DK, Parker LM, et al. Radar-guided localization and resection for metastatic nodal and soft tissue melanoma: a single-institution retrospective study. Cancer Control. 2024;31:10732748241237908. https:\/\/doi.org\/10.1177\/10732748241237907.","journal-title":"Cancer Control."},{"issue":"6","key":"17330_CR6","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1245\/s10434-020-09229-4","volume":"28","author":"KK Broman","year":"2021","unstructured":"Broman KK, Joyce D, Binitie O, et al. Intraoperative localization using an implanted radar reflector facilitates resection of non-palpable trunk and extremity sarcoma. Ann Surg Oncol. 2021;28(6):3366\u201374. https:\/\/doi.org\/10.1245\/s10434-020-09229-4.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"17330_CR7","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1177\/00031348211011135","volume":"88","author":"AB Chagpar","year":"2022","unstructured":"Chagpar AB, Garcia-Cantu C, Howard-McNatt MM, et al. Does localization technique matter for non-palpable breast cancers? Am Surg. 2022;88(12):2871\u20136. https:\/\/doi.org\/10.1177\/00031348211011135.","journal-title":"Am Surg."},{"issue":"4","key":"17330_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1245\/s10434-020-09159-1","volume":"28","author":"MK Srour","year":"2021","unstructured":"Srour MK, Kim S, Amersi F, Giuliano AE, Chung A. Comparison of multiple wire, radioactive seed, and savi scout((r)) radar localizations for management of surgical breast disease. Ann Surg Oncol. 2021;28(4):2212\u20138. https:\/\/doi.org\/10.1245\/s10434-020-09159-1.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"17330_CR9","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.21873\/anticanres.14352","volume":"40","author":"I Kasem","year":"2020","unstructured":"Kasem I, Mokbel K. Savi scout(r) radar localisation of non-palpable breast lesions: systematic review and pooled analysis of 842 cases. Anticancer Res. 2020;40(7):3633\u201343. https:\/\/doi.org\/10.21873\/anticanres.14352.","journal-title":"Anticancer Res."},{"issue":"8","key":"17330_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","volume":"18","author":"EZ Keung","year":"2018","unstructured":"Keung EZ, Gershenwald JE. The eighth edition American joint committee on cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018;18(8):775\u201384. https:\/\/doi.org\/10.1080\/14737140.2018.1489246.","journal-title":"Expert Rev Anticancer Ther"},{"key":"17330_CR11","unstructured":"Scout\u00ae Surgical Guidance System Console Operation Manual; 2021. https:\/\/www.Merit.Com\/wp-content\/uploads\/2021\/06\/scout-console-operation-manual_406025001_001.Pdf. Accessed December 16, 2024."},{"key":"17330_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246215","author":"C Clement","year":"2022","unstructured":"Clement C, Schops L, Nevelsteen I, et al. Retrospective cohort study of practical applications of paramagnetic seed localisation in breast carcinoma and other malignancies. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14246215.","journal-title":"Cancers"},{"issue":"9","key":"17330_CR13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5706","volume":"11","author":"M Beniey","year":"2019","unstructured":"Beniey M, Boulva K, Kaviani A, Patocskai E. Novel uses of radioactive seeds in surgical oncology: a case series. Cureus. 2019;11(9):e5706. https:\/\/doi.org\/10.7759\/cureus.5706.","journal-title":"Cureus."},{"issue":"3","key":"17330_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2214\/AJR.22.28399","volume":"220","author":"CJ Burke","year":"2023","unstructured":"Burke CJ, Schonberger A, Friedman EB, Berman RS, Adler RS. Image-guided radar reflector localization for small soft-tissue lesions in the musculoskeletal system. AJR Am J Roentgenol. 2023;220(3):399\u2013406. https:\/\/doi.org\/10.2214\/AJR.22.28399.","journal-title":"AJR Am J Roentgenol."},{"key":"17330_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clinimag.2017.07.020","volume":"47","author":"SN Patel","year":"2018","unstructured":"Patel SN, Mango VL, Jadeja P, et al. Reflector-guided breast tumor localization versus wire localization for lumpectomies: a comparison of surgical outcomes. Clin Imaging. 2018;47:14\u20137. https:\/\/doi.org\/10.1016\/j.clinimag.2017.07.020.","journal-title":"Clin Imaging."},{"issue":"6","key":"17330_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.acra.2018.07.002","volume":"26","author":"RW Woods","year":"2019","unstructured":"Woods RW, Camp MS, Durr NJ, Harvey SC. A review of options for localization of axillary lymph nodes in the treatment of invasive breast cancer. Acad Radiol. 2019;26(6):805\u201319. https:\/\/doi.org\/10.1016\/j.acra.2018.07.002.","journal-title":"Acad Radiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17330-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:57:54Z","timestamp":1748869074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["17330"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17330-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Michelle M. Dugan, Kate E. Beekman, Dr. Danielle K. DePalo, Lily M. Parker, and Dr. Kelly M. Elleson have no conflicts of interest or financial ties to disclose.\u00a0Dr. John E. Mullinax is an inventor on intellectual property that Moffitt Cancer Center has licensed to Iovance Biotherapeutics. He participates in sponsored research agreements with Iovance Biotherapeutics, Intellia Therapeutics, and SQZ Biotech that are not related to this research. He has received research support that is not related to this research from the following entities: NIH-NCI (K08CA252642), Ocala Royal Dames, and V Foundation. Dr. Mullinax has received consulting fees from Merit Medical, Lyell Therapeutics, and Iovance Biotherapeutics. Dr. Amod A. Sarnaik is a co-inventor on a patent application with Provectus Biopharmaceuticals. Dr. Sarnaik has received consulting fees from Iovance Biotherapeutics, Guidepoint, Defined Health, Huron Consulting Group, KeyQuest Health Inc, Istari, Rising Tide, and Gerson Lehrman Group. Dr. Sarnaik has received speaker fees from the Society for Immunotherapy of Cancer, Physicians\u2019 Educational Resource (PER) LLC, Medscape, and Medstar Health. Dr. Vernon K. Sondak serves in a consulting or advisory role for Merck\/Schering Plough, Novartis, Bristol Myers Squibb, Regeneron, Iovance Biotherapeutics, Alkermes, Ultimovacs, Genesis Drug Discovery & Development, and Sun Pharma. He has received research funding to the institution (Moffitt Cancer Center) from Neogene Therapeutics, Turnstone Bio, and Skyline Diagnostics, not related to this research. Dr. Matthew C. Perez has received consulting fees from Replimune and Guidepoint. Dr. Jonathan S. Zager has received payments from Delcath Systems \u2013 Medical Advisory Board. He has received fees from Philogen, Merit Medical, Castle Biosciences, Menarini Silicon Biosystems, Replimune and Merck. His department receives research funding from Philogen, SWOG, Delcath Systems, and Provectus. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This research was conducted under the approval of the Advarra IRB, approval number Pro00061990 (FWA 00023875), located in Columbia, Maryland (6100 Merriweather Drive, Suite 600, Columbia, MD, USA 21044), approved on March 9, 2022. The Advarra IRB deemed the study as exempt, and patient informed consent was not required","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}